Intracranial Hemorrhage Diagnosis & Treatment Market Research Report- Forecast to 2027

Intracranial Hemorrhage Diagnosis & Treatment Market: Information By Type (Intracerebral Hemorrhage, Subarachnoid Bleeding, Epidural Hematoma and Subdural Blood Hematoma), Diagnosis & Treatment (Diagnosis (CT, MRI, and Others) and Treatment (Medication and Surgery) and Region (Americas, Europe, Asia-Pacific and the Middle East & Africa) - Forecast till 2027

ID: MRFR/MED/2455-CR | January 2021 | Region: Global | 141 Pages         

Intracranial Hemorrhage Diagnosis and Treatment Market Speak to Analyst Request a Free Sample

Intracranial Hemorrhage Diagnosis and Treatment Market Overview

Based on the Intracranial Hemorrhage Diagnosis and Treatment Market Forecast, the market is expected to grow at a CAGR of 5.98% during the forecast period. The market had revenue of 1,493.98 million in 2019 and it is also expected to have an Intracranial Hemorrhage Diagnosis and Treatment Market Value of 2,221.2 million by the assessment period. Intracranial hemorrhage is a sort of brain damage in which the blood clots inside the skull. This increases the pressure in the brain and damages the brain tissues eventually.


Based on the report of WHO, road traffic crashes almost take 1.35 lives in a single year. Additionally, in most of the countries, 3% of their domestic products are being used in road traffic crashes. Apart from that, a notable journal article on Neurosurgery stated that around 69 million people all over the globe suffer from brain injuries due to some kind of trauma caused by various reasons; the Southern Asian Pacific and Western Pacific region will also experience the highest amount of diseases. Mostly, the number of road accidents will surely increase the growth of the Intracranial Hemorrhage Diagnosis and Treatment Market.


The market is gaining an impetus due to the rising number of accidents and traumatic brain injuries along with the advancement in surgeries. However, a lack of awareness about the various treatments available for traumatic brain injuries is likely to slow down the growth  


The market report consists of an overview, market dynamics such as drivers, opportunities, restraining factors, and challenges. Apart from that, it also discusses the market segmentation and regional analysis, and the major key players along with the competitive landscape of the market.


Global Intracranial Hemorrhage Diagnosis & Treatment Market Share, By Type, 2019 (%)Intracranial Hemorrhage Diagnosis & Treatment Market


Source: MRFR Analysis


Covid-19 impact


The covid-19 has taken a storm on all over the world. It has highly impacted the economies across the countries. Many industries have fallen and many had profits. Covid-19 having a serious impact on health and brain, the Intracranial Hemorrhage Diagnosis and Treatment Market has gained an impetus during the pandemic.


Market dynamics


According to the Intracranial Hemorrhage Diagnosis and Treatment Market Outlookthe market has several driving factors as well as restraining factors that are stated below.


Global Intracranial Hemorrhage Diagnosis & Treatment Market Share, By Region, 2019 (%)


Intracranial Hemorrhage Diagnosis & Treatment Market


Source: MRFR Analysis


Drivers


The increasing cases of accidents and trauma are the reason behind the growth of the Intracranial Hemorrhage Diagnosis and Treatment MarketThe increasing expenditure in the healthcare segment is boosting the growth of the market.


Opportunities


The increasing amount of geriatric population and the brain issues that are age-related are opening new opportunities to the Intracranial Hemorrhage Diagnosis and Treatment Market.


Challenges


The lack of awareness of the various treatments available is going to be a challenging factor for the market.


Restrains


As per the Intracranial Hemorrhage Diagnosis and Treatment Market Trendsthe complications associated with the brain surgeries along with the availability of counterfeit drugs are going to be the restraining factor of the Intracranial Hemorrhage Diagnosis and Treatment MarketApart from that, the lack of a skilled workforce is also negatively impacting the growth of the market.


Segmented overview


The Intracranial Hemorrhage Diagnosis and Treatment Market is segmented into-



  • Type

  • Devices

  • Diagnosis and treatment

  • Region


Based on type


Based on type, the is further segmented into-



  • Intracerebral Hemorrhage

  • Subarachnoid Bleeding

  • Epidural Hematoma

  • Subdural Blood Hematoma

  • Postpartum hemorrhage

  • Pulmonary hemorrhage


By devices


Based on devices, the Intracranial Hemorrhage Diagnosis and Treatment Market is further segmented into-



  • Invasive


o   Ventricular drainage pressure monitor


o   Lumbar drainage pressure monitors


o   Micro-transducer pressure monitor



  • Non-invasive


o   Tissue resonance analysis


o   Trans cranial popplar


Based on diagnosis and treatment


Based on diagnosis and treatment, the Intracranial Hemorrhage Diagnosis and Treatment Market is further segmented into-


Diagnosis

  • CT

  • MRI

  • Others


Treatment

  • Medication

  • Anti-Hypertensive Drugs

  • Coagulants

  • Others


Surgery

  • Decompression Surgery

  • Craniotomy with Open Surgery

  • Endoscopic Evacuation

  • Stereotactic Aspiration

  • Clipping or Coiling Procedures


Based on region

Based on region, the Intracranial Hemorrhage Diagnosis and Treatment Market is further segmented into-


Americas

  • North America

  • US

  • Canada

  • Latin America


Europe

  • Western Europe

  • Germany

  • France

  • UK

  • Italy

  • Spain

  • Rest of Western Europe

  • Eastern Europe


Asia-Pacific

  • China

  • Japan

  • India

  • Australia

  • South Korea

  • Rest of Asia-Pacific


Middle East & Africa

  • Middle East

  • Africa


Regional analysis


Primarily, the Americas is expected to witness the largest Intracranial Hemorrhage Diagnosis and Treatment Market Share during the forecast period. The huge growth in this region is due to the development of the healthcare sectors, investments in researches, people adopting advanced treatments, and the presence of some of the leading players. The increasing knowledge on Intracranial Hemorrhage Diagnosis & Treatment is expected to fuel the growth of the market in this region.


Based on the Intracranial Hemorrhage Diagnosis and Treatment Market Analysisthe European market is expected to witness substantial growth during the substantial period. The growth in this region is due to the increasing amount of accident cases, governments investing in researches, healthcare expenditures, and easy accessibility of advanced and various treatment facilities.


The Asia-Pacific region is anticipated to witness the fastest Intracranial Hemorrhage Diagnosis and Treatment Market Growth during the forecast period. The growth in this region is due to the increasing number of R&Ds, development in the healthcare sectors. The rising number of road accidents and thus traumatic injuries in the brain are also providing a boost to the growth of the market.


Owing to the development in healthcare sectors, the Middle East and Africa is expected to witness moderate growth and Intracranial Hemorrhage Diagnosis and Treatment Market Size during the assessment period.


Competitive landscape


The market is highly competitive because of the presence of major key players. They are hugely contributing to the market by launching a new product and investing in R&Ds.


Major key players


The major key players of the market are-



  • Canon Inc. (Japan)

  • FUJIFILM Holdings Corporation (Japan)

  • GE Healthcare (US)

  • Hitachi Ltd. (Japan)

  • Infrascan, inc. (US)

  • Johnson & Johnson (US)

  • Koninklijke Philips N.V. (Netherlands)

  • Medtronic plc (Ireland)

  • Siemens AG (Germany)

  • Stryker Corporation (US)


Report overview


The market consists of



  • Market overview

  • Market dynamics

  • Drivers

  • Opportunities

  • Restrains

  • Challenges

  • Segmented overview

  • Regional analysis

  • Competitive landscape

  • Recent developments

  • Major key players



Report Scope:

Report Attribute/Metric Details
  Market Size   2027: USD 1,493.98 Million
  CAGR   2018-2027: 5.98%
  Base Year   2020
  Forecast Period   2027
  Historical Data   2019
  Forecast Units   Value (USD Million)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors and Trends
  Segments Covered   Type and Diagnosis & Treatment
  Geographies Covered   North America, Europe, Asia-Pacific and Rest of the World (RoW)
  Key Vendors   Canon Inc. (Japan), FUJIFILM Holdings Corporation (Japan), GE Healthcare (US), Hitachi Ltd. (Japan), Infrascan, inc. (US), Johnson & Johnson (US), Koninklijke Philips N.V. (Netherlands), Medtronic plc (Ireland), Siemens AG (Germany), Stryker Corporation (US)
  Key Market Opportunities   Healthcare expenditure
  Key Market Drivers

  • Healthcare infrastructure
  • Research funding


  • Speak to Analyst Ask for Customization